Poultry Diagnostics Market to Reach US$ 847.6 Million with Growing at 8.5% CAGR by 2034 | Fact.MR Report
17 déc. 2024 07h30 HE
|
FACT.MR
Rockville, MD, Dec. 17, 2024 (GLOBE NEWSWIRE) -- As per this updated research report by Fact.MR, a market research and competitive intelligence provider, the global poultry diagnostics market is...
Point of Care Molecular Diagnostics Market Worth $5.38 Billion by 2028 - Exclusive Report by The Insight Partners
30 oct. 2023 05h27 HE
|
The Insight Partners
Pune, India, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Point-of-care molecular diagnostics include portable devices, and assays & kits used to detect and diagnose diseases in human samples, such as...
Revolutionizing Molecular Biology: Molecular Grade Plates Market to Witness Exponential Growth and Reach US$ 427.1 million by 2033, Persistence Market Research
25 mai 2023 10h10 HE
|
Persistence Market Research
New York, May 25, 2023 (GLOBE NEWSWIRE) -- The global molecular grade plates market is expected to generate US$ 277.8 million in revenue by the end of 2022, with a CAGR of 4.0% expected to propel...
Point of Care Molecular Diagnostics Market is Expected to Reach $4.1 billion | MarketsandMarkets.
24 avr. 2023 09h30 HE
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, April 24, 2023 (GLOBE NEWSWIRE) -- The point of care molecular diagnostics industry is expected to grow significantly in the near future. This is due to the increasing adoption of...
Influenza Diagnostics Market Size To Hit US$ 3.1 Billion By 2033, Owing To Increasing Investments in Healthcare Sector Globally | Persistence Market Research
23 mars 2023 22h20 HE
|
Persistence Market Research
New York, March 23, 2023 (GLOBE NEWSWIRE) -- The Influenza Diagnostics Market to reach a valuation of US$ 1.6 Billion in 2022 to US$ 3.1 Billion by the end of 2033, with at a CAGR of 6.1%. ...
Esoteric Testing Market Size & Share | North America, Europe, & APAC Industry Forecasts 2028: Graphical Research
22 nov. 2022 06h00 HE
|
Graphical Research
Pune, India, Nov. 22, 2022 (GLOBE NEWSWIRE) -- The global esoteric testing market size is predicted to witness remarkable growth during the forecast period, owing to rise in the frequency of rare...
ProPhase Labs Announces Record First Quarter 2022 Financial Results
13 mai 2022 08h30 HE
|
ProPhase Labs, Inc.
Record Net Revenues of $47.5 Million, Up 211% Year-over-Year Record Net Income of $12.5 Million, Increasing 1082% Year-over-Year Announces Special Cash Dividend of $0.30 per...
ProPhase Labs to Present at the Benzinga Healthcare Small Cap Conference
22 sept. 2021 08h30 HE
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Sept. 22, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, announces today that Chairman and CEO Ted Karkus will present at...
Precipio Signs HemeScreen™ Deals with Two Leading Oncology Groups
20 janv. 2021 10h00 HE
|
Precipio, Inc.
NEW HAVEN, Conn., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) has signed agreements with two of the largest oncology practices in the US,...
Precipio Launches its Proprietary HemeScreen™ AML (Acute Myeloid Leukemia) Molecular Panel
22 sept. 2020 10h30 HE
|
Precipio, Inc.
NEW HAVEN, Conn., Sept. 22, 2020 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that it has launched its HemeScreen™ AML (Acute Myeloid...